TCL Archive Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends December 9, 1988
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
